2,555 Shares in Axon Enterprise, Inc $AXON Acquired by North Dakota State Investment Board

North Dakota State Investment Board acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 2,555 shares of the biotechnology company’s stock, valued at approximately $1,451,000.

A number of other large investors have also recently made changes to their positions in AXON. New Millennium Group LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $29,000. Sound Income Strategies LLC grew its position in shares of Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $30,000. Root Financial Partners LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $34,000. Finally, Lodestone Wealth Management LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $35,000. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Erika Nardini sold 198 shares of Axon Enterprise stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the sale, the director owned 1,946 shares of the company’s stock, valued at $985,804.68. The trade was a 9.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the sale, the insider directly owned 55,588 shares of the company’s stock, valued at $29,740,135.88. The trade was a 3.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,855 shares of company stock valued at $7,109,828 over the last ninety days. 4.20% of the stock is owned by insiders.

Axon Enterprise Stock Down 1.8%

AXON stock opened at $392.34 on Wednesday. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91. The business has a fifty day moving average price of $425.17 and a 200-day moving average price of $508.74. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market capitalization of $31.62 billion, a P/E ratio of 157.57, a P/E/G ratio of 9.39 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter in the previous year, the business earned $1.47 earnings per share. The company’s revenue was up 33.7% on a year-over-year basis. Equities analysts forecast that Axon Enterprise, Inc will post 1.41 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on AXON. Citizens Jmp dropped their price target on Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating on the stock in a research report on Thursday, May 7th. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research report on Thursday, May 7th. Robert W. Baird set a $800.00 price target on Axon Enterprise in a research report on Wednesday, February 25th. Royal Bank Of Canada dropped their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Finally, Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.